TREM2 activator monoclonal antibody

This page covers all TREM2 activator monoclonal antibody drugs tracked by Drug Landscape: marketed products and active clinical-stage compounds, targeting TREM2.

Targets

TREM2

Marketed (1)

• AL003 · Alector Inc. · Neurology
  AL003 is a monoclonal antibody that activates TREM2 signaling on microglia to promote neuroinflammatory resolution and clearance of pathogenic proteins in the central nervous system.